Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LMNL

Liminal BioSciences (LMNL) Stock Price, News & Analysis

Liminal BioSciences logo

About Liminal BioSciences Stock (NASDAQ:LMNL)

Advanced Chart

Key Stats

Today's Range
$8.50
$8.50
50-Day Range
$8.38
$8.50
52-Week Range
$3.10
$8.50
Volume
N/A
Average Volume
63,470 shs
Market Capitalization
$26.35 million
P/E Ratio
29.31
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LMNL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liminal BioSciences and its competitors with MarketBeat's FREE daily newsletter.

LMNL Stock News Headlines

140% Yields From Stocks Like Tesla? Here's How (July 4th Special)
Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, Apple, and Amazon. And for the July 4th holiday...I'm sharing this secret for just $9.
See More Headlines

LMNL Stock Analysis - Frequently Asked Questions

Liminal BioSciences Inc. (NASDAQ:LMNL) released its quarterly earnings data on Monday, November, 15th. The company reported $27.40 EPS for the quarter, topping analysts' consensus estimates of ($2.80) by $30.20. The firm had revenue of $0.14 million for the quarter, compared to the consensus estimate of $0.02 million. Liminal BioSciences had a net margin of 248.35% and a negative trailing twelve-month return on equity of 88.44%.

Shares of Liminal BioSciences reverse split on the morning of Wednesday, February 1st 2023.The 1-10 reverse split was announced on Wednesday, February 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Liminal BioSciences investors own include Corbus Pharmaceuticals (CRBP), Bionano Genomics (BNGO), HubSpot (HUBS), iBio (IBIO), Dynavax Technologies (DVAX), Diamondback Energy (FANG) and NIO (NIO).

Company Calendar

Last Earnings
11/15/2021
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LMNL
Employees
251
Year Founded
N/A

Profitability

Trailing P/E Ratio
29.31
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$380 thousand
Pretax Margin
-5,729.40%

Debt

Sales & Book Value

Annual Sales
$310 thousand
Price / Cash Flow
N/A
Book Value
$8.97 per share
Price / Book
0.95

Miscellaneous

Free Float
3,036,000
Market Cap
$26.35 million
Optionable
Not Optionable
Beta
1.03
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:LMNL) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners